USA India Chamber of commerce - Delivering Affordable Innovation through Cross Border Partnerships

HOME

ABOUT US

STRUCTURE

AGENDA

COUNCILS

	US-INDIA INVESTMENT COUNCIL

	CIO COUNCIL

		CIO ADVISORS

	BIOTECH, PHARMACEUTICALS AND MEDICAL DEVICES COUNCIL
		BPM ADVISORS

POLICY & REPORTS

EVENTS

MEMBERSHIP

MEMBERSHIP FORM

INTERNSHIP/VOLUNTEERS

LEGAL

The USA-India Chamber of Commerce mission is to provide a pro-active and professional platform for senior business executives, industry associations and high ranking government officials in the United States and India to network, facilitate and promote trade, investments & economic cooperation. USAIC’s four point agenda is: Trade, Investment, Policy and Advocacy.

US India BioPharma & Healthcare Summit 2009 Delivering Affordable Innovation through Cross Border Partnerships			Bio Pharma & Healthcare Summit May 14, 2009 Registration
Dr. Manmohan Singh Honorable Prime Minister of India » Message	Mr. Kapil Sibal Honorable Minister of Science & Technology » Message	Mr. Kamal Nath Honorable Minister of Commerce & Industry » Message	Co-Chair 2009 Summit Dr. Martin Mackay President Global R&D Pfizer Hari Bhartia Co-Chairman & MD, Jubilant Dr. Naresh Trehan Chairman MediCity Jeff Elton Life Sciences Investor & Consultant USA India Chamber of Commerce commissioned McKinsey & Company Position Paper Summit Pics » 2008 » 2007 Media Coverage 2007-08 Meetings

Ashok Kumar, IAS, Secretary to Govt. of India, Department of Pharmaceuticals » Message	Dr. Martin Mackay, President Pfizer Global Research & Development	Hari S Bhartia Co - Chairman & Managing Director Jubilant Organosys	Nobel Laureate Prof. Sydney Altman Sterling Professor of Molecular Cellular & Devp. Biology	Dr. M.K.Bhan Secretary, Govt of India Department of Biotechnology » Message

Arun Jha Joint Secretary Department of Pharmaceuticals	Jeffrey Elton, PhD Life Sciences Investor & Consultant	Dr. David Lacey Senior Vice President & Head of Research Amgen	Jonathan Fleming Managing General Partner Oxford Bioscience Partners	K.V. Subramaniam President & CEO Reliance Life Sciences

Venkat Jasti Chairman & CEO Suven Life Sciences	Ismail Kola, PhD Senior VP, Discovery Research & CSO Schering-Plough Research Institute	Dr. Barry R. Bloom Harvard University Distinguished Service Professor & Past Dean Harvard School of Public Health	CSN Murthy Chief Executive Officer Aurigene	James C. Mullen, President & CEO Biogen Idec

Alan E. Smith, PhD Chief Scientific Officer Genzyme Corporation	Mr. J.A.S. Giri Chairman Sangfroid Industries	Noubar Afeyan, PhD Managing Partner and CEO Flagship Ventures	Art Pappas Managing Partner Pappas Ventures	William W.Chin,M.D. Vice President Discovery Research, Eli Lilly & Company

Reid J. Leonard Executive Director, Licensing & External Research Merck & Co. Inc.	Michael Rosenblatt Dean Tufts University School of Medicine	C Bhaktavatsala Rao, Dy. Managing Director Orchid Chemicals & Pharmaceuticals	Peter Barrett Partner Atlas Venture	Robert W.Armstrong Vice President Global External R&D, Eli Lilly & Company

Jeff Hanke Vice President - Cancer Discovery Astrazeneca	Dr. Lauren Silverman Managing Director Novartis Option Fund<	Joe Smith Vice President Emerging Technologies Johnson & Johnson	Patrick J Fortune Partner Boston Millennia Partners	Manni Kantipudi President GVK BIO

Dr. Eric Silfen Chief Medical Officer & Senior Vice President Philips Healthcare	Dr. Jerry Keusch Associate Dean Boston University School of Public Health	Marc N. Casper COO Thermo Fisher Scientific	Joseph Kvedar, MD Founder & Director Center for Connected Health	Dr. Goutam Dass Chief Operating Officer Syngene International